Share Price and Basic Stock Data
Last Updated: December 27, 2025, 10:22 pm
| PEG Ratio | 0.99 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Aarti Surfactants Ltd operates in the specialty chemicals sector, focusing on producing surfactants. The company’s market capitalization stood at ₹330 Cr, with its share price at ₹392. In terms of revenue, Aarti reported sales of ₹601 Cr for FY 2023, with trailing twelve months (TTM) sales reaching ₹760 Cr. The revenue showed a steady growth trajectory, rising from ₹576 Cr in FY 2022. However, the latest reported figure for FY 2024 sales declined slightly to ₹590 Cr, indicating potential challenges in maintaining revenue momentum. The quarterly sales figures illustrate fluctuations, with a peak of ₹215.90 Cr projected for June 2025, suggesting a recovery phase. The company’s operational performance, reflected in the operating profit margin (OPM), has been inconsistent, with OPM recorded at 6.88% for FY 2025, down from 10.55% in FY 2024. This variability in sales and margins indicates potential market pressures affecting overall revenue generation.
Profitability and Efficiency Metrics
Aarti Surfactants’ profitability metrics show a mixed picture. The net profit for FY 2025 was reported at ₹15 Cr, a decrease from ₹21 Cr in FY 2024, highlighting a concerning trend in profit retention. The company’s earnings per share (EPS) was ₹17.20 for FY 2025, down from ₹26.63 in FY 2024. The return on equity (ROE) stood at 5.14%, while the return on capital employed (ROCE) was recorded at 8.50%, both of which are below typical industry benchmarks. Efficiency indicators such as the cash conversion cycle (CCC) reported at 71 days reflect a relatively longer period for converting investments into cash, which could impede liquidity. The interest coverage ratio (ICR) at 3.93x suggests that the company is managing its debt obligations reasonably well. However, the declining net profit margin, which stood at 2.20% for FY 2025, raises concerns about cost management amid fluctuating sales and operational expenses.
Balance Sheet Strength and Financial Ratios
The balance sheet of Aarti Surfactants reflects a stable yet cautious financial position. Total assets as of FY 2025 were reported at ₹477 Cr, with total liabilities at ₹490 Cr, indicating a slight liability excess. The company maintained reserves of ₹228 Cr, providing a buffer for future investments or operational challenges. Borrowings stood at ₹118 Cr, with a debt-to-equity ratio of 0.37, suggesting a moderate level of leverage. However, the long-term debt-to-equity ratio of 0.02 indicates minimal reliance on long-term debt, which is a strength. The price-to-book value (P/BV) ratio of 1.46x suggests that the stock may be undervalued compared to its book value, potentially appealing to value investors. Despite these strengths, the company’s declining profitability metrics raise questions about its ability to sustain growth without addressing operational inefficiencies.
Shareholding Pattern and Investor Confidence
Aarti Surfactants’ shareholding pattern reveals a dominant promoter stake of 49.92%. The public holds 49.26%, while foreign institutional investors (FIIs) have a negligible presence at 0.00%. Domestic institutional investors (DIIs) account for only 0.80%, reflecting limited institutional interest. The total number of shareholders has decreased to 37,015, indicating a potential decline in retail investor confidence. The low participation from FIIs and DIIs suggests cautious sentiment regarding the company’s growth prospects. While the promoter holding has remained relatively stable, the lack of institutional backing may limit the stock’s upward momentum. The historical trend shows a decline in public shareholding from 54.05% in December 2022 to the current level, further illustrating waning investor confidence.
Outlook, Risks, and Final Insight
The outlook for Aarti Surfactants hinges on its ability to address profitability challenges while navigating a competitive chemicals market. The company’s declining net profit and fluctuating sales indicate potential risks, particularly in cost management and market positioning. Additionally, the weaker institutional interest may pose challenges for capital raising and stock liquidity. However, the stable promoter holding and manageable debt levels provide a degree of financial security. Should the company successfully implement operational efficiencies and enhance its market presence, there is potential for recovery in profitability and investor sentiment. Conversely, continued pressure on margins and lack of institutional support could hinder growth prospects. The company must focus on optimizing its operational strategy to leverage market opportunities while mitigating inherent risks.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 393 Cr. | 42.8 | 83.5/41.2 | 24.4 | 20.5 | 0.94 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 30.8 Cr. | 62.8 | 91.9/56.0 | 14.8 | 89.6 | 1.59 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 50.2 Cr. | 738 | 932/600 | 23.1 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,385 Cr. | 74.7 | 111/74.0 | 22.4 | 22.0 | 0.67 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 643 Cr. | 258 | 393/241 | 23.1 | 93.8 | 0.97 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,820.00 Cr | 725.64 | 70.22 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 151.77 | 133.55 | 157.84 | 148.70 | 143.86 | 138.75 | 158.55 | 143.41 | 150.84 | 162.78 | 202.05 | 215.90 | 179.17 |
| Expenses | 143.00 | 119.98 | 143.94 | 133.90 | 127.60 | 122.02 | 144.21 | 133.79 | 147.12 | 153.89 | 182.36 | 204.27 | 169.83 |
| Operating Profit | 8.77 | 13.57 | 13.90 | 14.80 | 16.26 | 16.73 | 14.34 | 9.62 | 3.72 | 8.89 | 19.69 | 11.63 | 9.34 |
| OPM % | 5.78% | 10.16% | 8.81% | 9.95% | 11.30% | 12.06% | 9.04% | 6.71% | 2.47% | 5.46% | 9.75% | 5.39% | 5.21% |
| Other Income | 0.09 | 0.06 | 0.09 | 0.03 | 0.03 | 0.03 | 0.05 | 0.49 | 6.21 | -0.16 | 1.14 | 0.04 | 0.06 |
| Interest | 3.74 | 4.16 | 3.91 | 3.32 | 3.66 | 3.65 | 3.41 | 2.57 | 2.60 | 3.12 | 3.26 | 3.28 | 2.80 |
| Depreciation | 4.06 | 4.01 | 3.93 | 3.95 | 3.85 | 4.02 | 4.21 | 4.23 | 4.31 | 4.40 | 4.41 | 4.35 | 4.41 |
| Profit before tax | 1.06 | 5.46 | 6.15 | 7.56 | 8.78 | 9.09 | 6.77 | 3.31 | 3.02 | 1.21 | 13.16 | 4.04 | 2.19 |
| Tax % | 69.81% | 27.11% | 23.90% | 30.56% | 45.90% | 26.40% | 31.17% | 32.93% | 40.07% | 33.88% | 26.22% | 27.23% | 29.22% |
| Net Profit | 0.32 | 3.98 | 4.69 | 5.25 | 4.74 | 6.68 | 4.65 | 2.22 | 1.81 | 0.80 | 9.72 | 2.94 | 1.56 |
| EPS in Rs | 0.38 | 4.68 | 5.52 | 6.18 | 5.58 | 7.86 | 5.50 | 2.62 | 2.14 | 0.95 | 11.49 | 3.48 | 1.84 |
Last Updated: December 28, 2025, 10:35 am
Below is a detailed analysis of the quarterly data for Aarti Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 179.17 Cr.. The value appears to be declining and may need further review. It has decreased from 215.90 Cr. (Jun 2025) to 179.17 Cr., marking a decrease of 36.73 Cr..
- For Expenses, as of Sep 2025, the value is 169.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 204.27 Cr. (Jun 2025) to 169.83 Cr., marking a decrease of 34.44 Cr..
- For Operating Profit, as of Sep 2025, the value is 9.34 Cr.. The value appears to be declining and may need further review. It has decreased from 11.63 Cr. (Jun 2025) to 9.34 Cr., marking a decrease of 2.29 Cr..
- For OPM %, as of Sep 2025, the value is 5.21%. The value appears to be declining and may need further review. It has decreased from 5.39% (Jun 2025) to 5.21%, marking a decrease of 0.18%.
- For Other Income, as of Sep 2025, the value is 0.06 Cr.. The value appears strong and on an upward trend. It has increased from 0.04 Cr. (Jun 2025) to 0.06 Cr., marking an increase of 0.02 Cr..
- For Interest, as of Sep 2025, the value is 2.80 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.28 Cr. (Jun 2025) to 2.80 Cr., marking a decrease of 0.48 Cr..
- For Depreciation, as of Sep 2025, the value is 4.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.35 Cr. (Jun 2025) to 4.41 Cr., marking an increase of 0.06 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.19 Cr.. The value appears to be declining and may need further review. It has decreased from 4.04 Cr. (Jun 2025) to 2.19 Cr., marking a decrease of 1.85 Cr..
- For Tax %, as of Sep 2025, the value is 29.22%. The value appears to be increasing, which may not be favorable. It has increased from 27.23% (Jun 2025) to 29.22%, marking an increase of 1.99%.
- For Net Profit, as of Sep 2025, the value is 1.56 Cr.. The value appears to be declining and may need further review. It has decreased from 2.94 Cr. (Jun 2025) to 1.56 Cr., marking a decrease of 1.38 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.84. The value appears to be declining and may need further review. It has decreased from 3.48 (Jun 2025) to 1.84, marking a decrease of 1.64.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:21 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 326 | 466 | 576 | 601 | 590 | 659 | 760 |
| Expenses | 302 | 420 | 543 | 554 | 528 | 617 | 710 |
| Operating Profit | 24 | 46 | 32 | 48 | 62 | 42 | 50 |
| OPM % | 7% | 10% | 6% | 8% | 11% | 6% | 7% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 8 | 1 |
| Interest | 10 | 10 | 11 | 15 | 14 | 12 | 12 |
| Depreciation | 11 | 12 | 12 | 15 | 16 | 17 | 18 |
| Profit before tax | 3 | 23 | 9 | 18 | 32 | 21 | 21 |
| Tax % | 29% | 6% | 41% | 29% | 34% | 30% | |
| Net Profit | 2 | 22 | 5 | 13 | 21 | 15 | 15 |
| EPS in Rs | 2.46 | 25.45 | 6.46 | 14.94 | 25.22 | 17.19 | 17.76 |
| Dividend Payout % | 0% | 11% | 0% | 0% | 0% | 6% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1000.00% | -77.27% | 160.00% | 61.54% | -28.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1077.27% | 237.27% | -98.46% | -90.11% |
Aarti Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 28% |
| TTM: | -31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | -17% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 8% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:01 pm
Balance Sheet
Last Updated: December 4, 2025, 2:16 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 103 | 125 | 128 | 160 | 210 | 224 | 228 |
| Borrowings | 109 | 152 | 162 | 149 | 99 | 110 | 118 |
| Other Liabilities | 42 | 102 | 105 | 86 | 105 | 134 | 135 |
| Total Liabilities | 262 | 387 | 402 | 404 | 422 | 477 | 490 |
| Fixed Assets | 151 | 187 | 173 | 207 | 208 | 204 | 201 |
| CWIP | 14 | 20 | 52 | 8 | 8 | 15 | 29 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 97 | 180 | 178 | 188 | 206 | 259 | 260 |
| Total Assets | 262 | 387 | 402 | 404 | 422 | 477 | 490 |
Below is a detailed analysis of the balance sheet data for Aarti Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 228.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Mar 2025) to 228.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 118.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 110.00 Cr. (Mar 2025) to 118.00 Cr., marking an increase of 8.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 135.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 134.00 Cr. (Mar 2025) to 135.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 490.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 477.00 Cr. (Mar 2025) to 490.00 Cr., marking an increase of 13.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 201.00 Cr.. The value appears to be declining and may need further review. It has decreased from 204.00 Cr. (Mar 2025) to 201.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 14.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 260.00 Cr.. The value appears strong and on an upward trend. It has increased from 259.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 490.00 Cr.. The value appears strong and on an upward trend. It has increased from 477.00 Cr. (Mar 2025) to 490.00 Cr., marking an increase of 13.00 Cr..
Notably, the Reserves (228.00 Cr.) exceed the Borrowings (118.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -85.00 | -106.00 | -130.00 | -101.00 | -37.00 | -68.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 20 | 43 | 35 | 40 | 43 | 42 |
| Inventory Days | 83 | 76 | 60 | 60 | 81 | 92 |
| Days Payable | 28 | 81 | 56 | 44 | 55 | 63 |
| Cash Conversion Cycle | 75 | 38 | 38 | 55 | 69 | 71 |
| Working Capital Days | -1 | 3 | 16 | 20 | 40 | 36 |
| ROCE % | 13% | 7% | 11% | 15% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 17.20 | 26.63 | 16.64 | 7.25 | 28.53 |
| Diluted EPS (Rs.) | 17.19 | 25.16 | 16.47 | 7.25 | 28.53 |
| Cash EPS (Rs.) | 37.67 | 44.13 | 35.50 | 23.65 | 44.62 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 274.78 | 257.64 | 211.58 | 179.20 | 174.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 274.78 | 257.64 | 211.58 | 179.20 | 174.90 |
| Revenue From Operations / Share (Rs.) | 778.53 | 696.75 | 757.16 | 758.81 | 614.11 |
| PBDIT / Share (Rs.) | 53.62 | 73.54 | 60.53 | 42.76 | 60.08 |
| PBIT / Share (Rs.) | 33.13 | 54.60 | 41.03 | 26.35 | 43.98 |
| PBT / Share (Rs.) | 24.45 | 38.02 | 22.41 | 12.29 | 30.21 |
| Net Profit / Share (Rs.) | 17.18 | 25.19 | 16.00 | 7.24 | 28.52 |
| NP After MI And SOA / Share (Rs.) | 17.18 | 25.19 | 16.00 | 7.24 | 28.52 |
| PBDIT Margin (%) | 6.88 | 10.55 | 7.99 | 5.63 | 9.78 |
| PBIT Margin (%) | 4.25 | 7.83 | 5.41 | 3.47 | 7.16 |
| PBT Margin (%) | 3.14 | 5.45 | 2.96 | 1.61 | 4.91 |
| Net Profit Margin (%) | 2.20 | 3.61 | 2.11 | 0.95 | 4.64 |
| NP After MI And SOA Margin (%) | 2.20 | 3.61 | 2.11 | 0.95 | 4.64 |
| Return on Networth / Equity (%) | 6.25 | 9.77 | 7.56 | 4.04 | 16.30 |
| Return on Capital Employeed (%) | 9.64 | 15.77 | 12.73 | 7.88 | 15.02 |
| Return On Assets (%) | 3.04 | 5.05 | 3.15 | 1.36 | 5.59 |
| Long Term Debt / Equity (X) | 0.02 | 0.12 | 0.31 | 0.62 | 0.46 |
| Total Debt / Equity (X) | 0.37 | 0.34 | 0.76 | 1.04 | 0.99 |
| Asset Turnover Ratio (%) | 1.47 | 1.43 | 1.49 | 1.46 | 1.44 |
| Current Ratio (X) | 1.35 | 1.54 | 1.26 | 1.17 | 1.07 |
| Quick Ratio (X) | 0.63 | 0.77 | 0.73 | 0.67 | 0.62 |
| Inventory Turnover Ratio (X) | 5.64 | 5.05 | 6.15 | 6.25 | 5.49 |
| Interest Coverage Ratio (X) | 3.93 | 4.44 | 3.25 | 3.04 | 4.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.90 | 2.52 | 1.86 | 1.52 | 3.07 |
| Enterprise Value (Cr.) | 446.96 | 559.15 | 501.39 | 729.76 | 852.31 |
| EV / Net Operating Revenue (X) | 0.67 | 0.94 | 0.83 | 1.27 | 1.83 |
| EV / EBITDA (X) | 9.85 | 8.98 | 10.43 | 22.50 | 18.71 |
| MarketCap / Net Operating Revenue (X) | 0.51 | 0.79 | 0.59 | 0.98 | 1.52 |
| Price / BV (X) | 1.46 | 2.15 | 2.14 | 4.19 | 5.33 |
| Price / Net Operating Revenue (X) | 0.51 | 0.79 | 0.59 | 0.98 | 1.52 |
| EarningsYield | 0.04 | 0.04 | 0.03 | 0.01 | 0.03 |
After reviewing the key financial ratios for Aarti Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.20. This value is within the healthy range. It has decreased from 26.63 (Mar 24) to 17.20, marking a decrease of 9.43.
- For Diluted EPS (Rs.), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 25.16 (Mar 24) to 17.19, marking a decrease of 7.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 37.67. This value is within the healthy range. It has decreased from 44.13 (Mar 24) to 37.67, marking a decrease of 6.46.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 274.78. It has increased from 257.64 (Mar 24) to 274.78, marking an increase of 17.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 274.78. It has increased from 257.64 (Mar 24) to 274.78, marking an increase of 17.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 778.53. It has increased from 696.75 (Mar 24) to 778.53, marking an increase of 81.78.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 53.62. This value is within the healthy range. It has decreased from 73.54 (Mar 24) to 53.62, marking a decrease of 19.92.
- For PBIT / Share (Rs.), as of Mar 25, the value is 33.13. This value is within the healthy range. It has decreased from 54.60 (Mar 24) to 33.13, marking a decrease of 21.47.
- For PBT / Share (Rs.), as of Mar 25, the value is 24.45. This value is within the healthy range. It has decreased from 38.02 (Mar 24) to 24.45, marking a decrease of 13.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 17.18. This value is within the healthy range. It has decreased from 25.19 (Mar 24) to 17.18, marking a decrease of 8.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.18. This value is within the healthy range. It has decreased from 25.19 (Mar 24) to 17.18, marking a decrease of 8.01.
- For PBDIT Margin (%), as of Mar 25, the value is 6.88. This value is below the healthy minimum of 10. It has decreased from 10.55 (Mar 24) to 6.88, marking a decrease of 3.67.
- For PBIT Margin (%), as of Mar 25, the value is 4.25. This value is below the healthy minimum of 10. It has decreased from 7.83 (Mar 24) to 4.25, marking a decrease of 3.58.
- For PBT Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 10. It has decreased from 5.45 (Mar 24) to 3.14, marking a decrease of 2.31.
- For Net Profit Margin (%), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 5. It has decreased from 3.61 (Mar 24) to 2.20, marking a decrease of 1.41.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 8. It has decreased from 3.61 (Mar 24) to 2.20, marking a decrease of 1.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.25. This value is below the healthy minimum of 15. It has decreased from 9.77 (Mar 24) to 6.25, marking a decrease of 3.52.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.64. This value is below the healthy minimum of 10. It has decreased from 15.77 (Mar 24) to 9.64, marking a decrease of 6.13.
- For Return On Assets (%), as of Mar 25, the value is 3.04. This value is below the healthy minimum of 5. It has decreased from 5.05 (Mar 24) to 3.04, marking a decrease of 2.01.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.12 (Mar 24) to 0.02, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from 0.34 (Mar 24) to 0.37, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.47. It has increased from 1.43 (Mar 24) to 1.47, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 24) to 1.35, marking a decrease of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has decreased from 0.77 (Mar 24) to 0.63, marking a decrease of 0.14.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.64. This value is within the healthy range. It has increased from 5.05 (Mar 24) to 5.64, marking an increase of 0.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.93. This value is within the healthy range. It has decreased from 4.44 (Mar 24) to 3.93, marking a decrease of 0.51.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 3. It has decreased from 2.52 (Mar 24) to 1.90, marking a decrease of 0.62.
- For Enterprise Value (Cr.), as of Mar 25, the value is 446.96. It has decreased from 559.15 (Mar 24) to 446.96, marking a decrease of 112.19.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.67, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 9.85. This value is within the healthy range. It has increased from 8.98 (Mar 24) to 9.85, marking an increase of 0.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.51, marking a decrease of 0.28.
- For Price / BV (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has decreased from 2.15 (Mar 24) to 1.46, marking a decrease of 0.69.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.51, marking a decrease of 0.28.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aarti Surfactants Ltd:
- Net Profit Margin: 2.2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.64% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.25% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.9
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.1 (Industry average Stock P/E: 70.22)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.2%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Plot Nos. 57, 58, 60 to 64, 62A, S-3/1, Dhar District Madhya Pradesh 454775 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mulesh Manilal Savla | Chairman(NonExe.&Ind.Director) |
| Mr. Nikhil Parimal Desai | Managing Director & CEO |
| Mr. Santosh Madhaorao Kakade | Executive Director |
| Mr. Chandrakant Vallabhaji Gogri | Non Exe.Non Ind.Director |
| Mr. Dattatray Sidram Galpalli | Non Exe.Non Ind.Director |
| Mrs. Misha Bharat Gala | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Aarti Surfactants Ltd?
Aarti Surfactants Ltd's intrinsic value (as of 28 December 2025) is 255.09 which is 34.93% lower the current market price of 392.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 332 Cr. market cap, FY2025-2026 high/low of 668/382, reserves of ₹228 Cr, and liabilities of 490 Cr.
What is the Market Cap of Aarti Surfactants Ltd?
The Market Cap of Aarti Surfactants Ltd is 332 Cr..
What is the current Stock Price of Aarti Surfactants Ltd as on 28 December 2025?
The current stock price of Aarti Surfactants Ltd as on 28 December 2025 is 392.
What is the High / Low of Aarti Surfactants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Aarti Surfactants Ltd stocks is 668/382.
What is the Stock P/E of Aarti Surfactants Ltd?
The Stock P/E of Aarti Surfactants Ltd is 22.1.
What is the Book Value of Aarti Surfactants Ltd?
The Book Value of Aarti Surfactants Ltd is 280.
What is the Dividend Yield of Aarti Surfactants Ltd?
The Dividend Yield of Aarti Surfactants Ltd is 0.25 %.
What is the ROCE of Aarti Surfactants Ltd?
The ROCE of Aarti Surfactants Ltd is 8.50 %.
What is the ROE of Aarti Surfactants Ltd?
The ROE of Aarti Surfactants Ltd is 5.14 %.
What is the Face Value of Aarti Surfactants Ltd?
The Face Value of Aarti Surfactants Ltd is 10.0.